-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on IDEAYA Biosciences, Lowers Price Target to $55

Benzinga·11/20/2026 18:01:29
Listen to the news
JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight and lowers the price target from $62 to $55.